Butterfly Network's Cashman Steve Buys 53k Shares at $1.63-$1.64/Share on 2025-08-25
ByAinvest
Wednesday, Aug 27, 2025 9:06 am ET1min read
BFLY--
Steve's investments come at a critical juncture for Butterfly Network, which has been making strides in the digital health sector. The company specializes in portable, semiconductor-based ultrasound technology, intuitive software, and educational offerings. Its flagship products, the second-generation Butterfly iQ+ and third-generation Butterfly iQ3, are powered by Ultrasound-on-Chip technology, enabling whole-body imaging with a single handheld probe. Butterfly Network's cloud-based software solutions, teleguidance, and educational programs further enhance its offerings.
The company's recent partnership with HeartFocus, an AI-guided cardiac imaging software developed by DESKi, has also been a significant milestone. HeartFocus, cleared by the FDA, allows any healthcare professional to conduct diagnostic-quality heart ultrasounds after minimal training. This integration with Butterfly Network's handheld ultrasound devices addresses persistent barriers in cardiac care, such as limited access to trained sonographers and long wait times for diagnostic imaging.
Steve's investment aligns with Butterfly Network's mission to democratize medical imaging, making high-quality ultrasound affordable, easy-to-use, and globally accessible. The company's disruptive technology has been recognized with numerous accolades, including TIME’s Best Inventions, Fast Company’s World Changing Ideas, and CNBC Disruptor 50. With its proprietary Ultrasound-on-Chip™ technology and intelligent software, Butterfly Network is paving the way for mass adoption of ultrasound for earlier detection and remote management of health conditions worldwide.
References:
[1] https://www.marketscreener.com/news/clipper-distributing-and-butterfly-network-announce-new-agreement-ce7c50d8d880ff24
[2] https://www.morningstar.com/news/business-wire/20250827820141/heartfocus-launches-first-clinical-product-in-the-us-with-butterfly-network
Butterfly Network, Inc. (BFLY) has announced that Chief Business Officer, Cashman Steve, has made significant investments in the company's shares. Specifically, Steve purchased 4,709 shares at a price of $1.63 per share on August 25, 2025, and subsequently acquired an additional 45,291 shares at a price of $1.64 per share on the same date. These transactions demonstrate Steve's confidence in the company's prospects and highlight his commitment to Butterfly Network's long-term growth and success.
Butterfly Network Inc. (BFLY) has recently seen significant investment from its Chief Business Officer, Cashman Steve. On August 25, 2025, Steve purchased 4,709 shares at a price of $1.63 per share, followed by an additional acquisition of 45,291 shares at $1.64 per share on the same date. These transactions underscore Steve's confidence in the company's prospects and his commitment to Butterfly Network's long-term growth and success.Steve's investments come at a critical juncture for Butterfly Network, which has been making strides in the digital health sector. The company specializes in portable, semiconductor-based ultrasound technology, intuitive software, and educational offerings. Its flagship products, the second-generation Butterfly iQ+ and third-generation Butterfly iQ3, are powered by Ultrasound-on-Chip technology, enabling whole-body imaging with a single handheld probe. Butterfly Network's cloud-based software solutions, teleguidance, and educational programs further enhance its offerings.
The company's recent partnership with HeartFocus, an AI-guided cardiac imaging software developed by DESKi, has also been a significant milestone. HeartFocus, cleared by the FDA, allows any healthcare professional to conduct diagnostic-quality heart ultrasounds after minimal training. This integration with Butterfly Network's handheld ultrasound devices addresses persistent barriers in cardiac care, such as limited access to trained sonographers and long wait times for diagnostic imaging.
Steve's investment aligns with Butterfly Network's mission to democratize medical imaging, making high-quality ultrasound affordable, easy-to-use, and globally accessible. The company's disruptive technology has been recognized with numerous accolades, including TIME’s Best Inventions, Fast Company’s World Changing Ideas, and CNBC Disruptor 50. With its proprietary Ultrasound-on-Chip™ technology and intelligent software, Butterfly Network is paving the way for mass adoption of ultrasound for earlier detection and remote management of health conditions worldwide.
References:
[1] https://www.marketscreener.com/news/clipper-distributing-and-butterfly-network-announce-new-agreement-ce7c50d8d880ff24
[2] https://www.morningstar.com/news/business-wire/20250827820141/heartfocus-launches-first-clinical-product-in-the-us-with-butterfly-network

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet